
Results
8
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
8 companies
Celon Pharma
Market Cap: zł1.1b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł20.70
7D
-0.5%
1Y
-12.5%
Selvita
Market Cap: zł611.2m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł33.30
7D
4.7%
1Y
-4.3%
Ryvu Therapeutics
Market Cap: zł523.7m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł22.65
7D
-3.0%
1Y
-30.6%
Poltreg
Market Cap: zł90.9m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł19.50
7D
12.4%
1Y
-45.5%
Biogened
Market Cap: zł44.5m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł18.10
7D
-7.2%
1Y
-40.8%
Genomed Spólka Akcyjna
Market Cap: zł31.7m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł24.00
7D
-5.5%
1Y
0%
Stem Cells Spin
Market Cap: zł18.2m
Operates as a biotechnology company in Poland.
SCS
zł0.44
7D
10.0%
1Y
134.0%
Labocanna
Market Cap: zł4.4m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.21
7D
0.5%
1Y
-36.9%